KLK6 and malignant colon neoplasm: We employed HCT116 isogenic colon cancer cell model with the negative control cells (HCT116-control shRNA) and cells with knockdown expression of KLK6 (HCT116-KLK6 shRNA cells) and followed cells in culture for 2 weeks.